What We Do
Transformative Therapies for Autoimmune Disease
Translating the biology of regulatory T cells into transformational medicines for patients.
The Abata Approach
A New Era: Treg Cell Therapy
Our targeted, autologous Treg cell therapies for progressive multiple sclerosis and other serious autoimmune diseases stop immune-mediated destruction, restore homeostasis – a state of harmony – and promote repair in affected tissues.

Press Release
Abata Announces Formation of Advisory Board Comprised of Leading Industry Experts in Treg Biology, Cell Therapy and Corporate Development
Abata Advisory Board to be chaired by Abata co-founder Diane Mathis, Ph.D. Additional members include renowned industry leaders: John Maraganore, Ph.D.; Charles Cooney, Ph.D.; and Gerald Nepom, M.D., Ph.D.